Xeris Biopharma Holdings, Inc. is an overlooked specialty pharmaceutical company with three FDA-approved products ...

Acute Migraine Treatment MarketThe global migraine treatment market is anticipated to achieve a valuation of USD 3.2 billion ...

Eli Lilly LLY.N said on Monday it sued three medical spas and online vendors for selling products claiming to contain ...

Global Gene Therapy in CNS Disorder IndustryThe global gene therapy market for central nervous system (CNS) disorders is set ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Boyd Watterson Asset Management LLC OH trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.3% during ...

New results show Eli Lilly’s Ebglyss improved skin and itch among patients with moderate-to-severe atopic dermatitis who were previously treated with dupilumab. These results fr ...

Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of ...

Yesoul, a rising star in the exercise equipment world, is thrilled to announce the launch of its latest treadmill designed to ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...